Emily G. Hoffman, Ninoschka C. D'Souza, Richard T. Liggins, & Michael C. Riddell. (2024). Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes. Frontiers Media S.A..
Chicago Style (17th ed.) CitationEmily G. Hoffman, Ninoschka C. D'Souza, Richard T. Liggins, and Michael C. Riddell. Pharmacologic Inhibition of Somatostatin Receptor 2 to Restore Glucagon Counterregulation in Diabetes. Frontiers Media S.A., 2024.
MLA (9th ed.) CitationEmily G. Hoffman, et al. Pharmacologic Inhibition of Somatostatin Receptor 2 to Restore Glucagon Counterregulation in Diabetes. Frontiers Media S.A., 2024.
Warning: These citations may not always be 100% accurate.